• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Technology

Ypsomed, CamDiab continue global insulin pump iPhone software rollout

June 18, 2025 By Sean Whooley

mylife loop camdiab ypsomed abbott freestyle libre 3

Ypsomed and CamDiab announced that they continued the launch of the iOS version of their automated insulin delivery app in Europe. The two companies in March began the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms. In combination with the mylife YpsoPump, the offering enables people with type 1 diabetes to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: CamDiab, Ypsomed

Dexcom has a Class I CGM receiver recall

June 17, 2025 By Sean Whooley

Dexcom One+ CGM phone and receiver (1)

The FDA’s recall database today posted notices related to a Class I recall for continuous glucose monitor (CGM) components made by Dexcom (Nasdaq:DXCM). Dexcom’s recalls relate to its Dexcom One and One+ offerings and the G6 and G7 CGMs. The One and One+ systems, which are mainly the company’s commercial CGM offering outside the U.S., feature […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Dexcom, FDA

Medtronic to invest $50M in India Diabetes center

June 17, 2025 By Sean Whooley

Medtronic Diabetes Investment in Pune India

Medtronic (NYSE:MDT) announced that it inaugurated a new Diabetes Global Capability Center in India with a significant investment. The medtech giant said it plans to invest $50 million over five years in the Pune, India location. In a post on LinkedIn, Medtronic said: “We are proud to mark a significant milestone with the inauguration of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Medtronic

Flat Medical partners with Mercury Medical on smart syringe distribution

June 16, 2025 By Sean Whooley

Flat Medical EpiFaith Smart Syringe

Flat Medical announced today that it inked a dealership agreement with Mercury Medical to distribute its EpiFaith smart syringe in the U.S. Austin, Texas-based Flat designed EpiFaith to transform epidural procedures, according to a news release. It converts the tactile loss-of-resistance technique into an objective visual signal. The breakthrough technology enables anesthesia providers to identify […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: Flat Medical, Mercury Medical

Glucotrack to effect a reverse stock split

June 13, 2025 By Sean Whooley

GlucoTrack updated Logo (1)

Glucotrack (Nasdaq:GCTK) announced that it plans to effect a 1-for-60 reverse stock split of its issued and outstanding common stock. Rutherford, New Jersey-based Glucotrack — maker of a long-term implantable continuous blood glucose monitor (CBGM) — intends for the split to go into effect when the market opens on Monday, June 16, 2025. Under the terms […]

Filed Under: Business/Financial News, Diabetes, Featured, Implants, Patient Monitoring, Technology, Wall Street Beat Tagged With: Glucotrack

Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit

June 12, 2025 By Sean Whooley

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Medtronic (NYSE:MDT) announced today that it selected “MiniMed” as the name for its Diabetes unit following its planned separation. The medtech giant announced last month that it planned to separate the Diabetes unit. The move sought to create “a more focused Medtronic” with a more simplified portfolio in high-margin growth markets. At the same time, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Medtronic, minimed

Insulet, Marvel collab to unveil comic book hero with type 1 diabetes

June 11, 2025 By Sean Whooley

Insulet Omnipod Dyasonic Marvel hero with diabetes (1) (1)

Insulet (Nasdaq:PODD) announced today that it partnered with Marvel to launch a comic book featuring a hero with type 1 diabetes. The companies collaborated on the comic to help make people with diabetes feel seen, understood and represented. This marks another initiative for the Acton, Massachusetts-based automated insulin pump maker to promote inclusivity and representation. […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Insulet

Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7

June 10, 2025 By Sean Whooley

Insulet Omnipod 5 with Dexcom G7

Insulet (Nasdaq:PODD) today announced the compatibility of its Omnipod 5 App for iPhone with Dexcom G7 continuous glucose monitor (CGM). The latest integration combines the benefits of the companies’ latest technologies, all conveniently controlled from an iPhone. Omnipod 5, the first FDA-cleared tubeless automated insulin delivery system, communicates with a CGM, such as G7. It […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Insulet

Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

June 10, 2025 By Sean Whooley

Tandem Abbott Mobi FreeStyle Libre

Tandem Diabetes Care (Nasdaq:TNDM) today announced an agreement to develop and commercialize diabetes tech with Abbott (NYSE:ABT). San Diego–based Tandem said it agreed to combine its insulin delivery systems with Abbott’s future dual glucose-ketone sensor. The companies aim to provide more options for people to manage their diabetes. This marks the second recent collaboration announcement […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Tandem Diabetes Care

Roche, IBM collab on predictive AI for CGM tech

June 9, 2025 By Sean Whooley

Roche Accu-Chek SmartGuide IBM Predict

Roche and IBM recently announced the development of an AI-enabled solution to predict glucose levels through continuous glucose monitors (CGMs). Together, the companies developed the AI-based Accu-Chek SmartGuide Predict app. They said in a news release that they launched the solution in Switzerland earlier this year. Roche first unveiled its Accu-Chek SmartGuide in an event at […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Roche, Roche Diabetes Care

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Interim pages omitted …
  • Page 75
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS